Director of Clinical Development — Rare Disease Lead

Eloxx Pharmaceuticals; Boston; On-site; GBP 111,748 - 148,998; Full time

Benefits offered by this job

Competitive salary and benefits

Equity opportunities

Mission-driven culture

Job summary

A growing healthcare company in Boston is seeking a Director to provide leadership for Phase 2 clinical trials in rare diseases like Alport Syndrome and ADPKD. The ideal candidate will have an MD with a nephrology specialty, proven Phase 2 program experience, and exceptional communication skills. This role offers a competitive salary, meaningful equity, and the chance to make a significant impact on patient care.

Qualifications

• Proven experience leading Phase 2 clinical programs; rare disease background valued.
• Hands-on, execution-oriented style.
• Personable and firm, able to build trust while driving accountability.
• Willing to work regularly on-site in the Boston area.

Responsibilities

• Provide medical and strategic leadership for Phase 2 trials in Alport Syndrome and ADPKD.
• Oversee protocol development, IND submissions, site activation, and trial execution.
• Build and strengthen relationships with treating physicians and patient advocacy organizations.

Skills

Nephrology specialty

Communication skills

Leadership

Education

MD

Job description

A growing healthcare company in Boston is seeking a Director to provide leadership for Phase 2 clinical trials in rare diseases like Alport Syndrome and ADPKD. The ideal candidate will have an MD with a nephrology specialty, proven Phase 2 program experience, and exceptional communication skills. This role offers a competitive salary, meaningful equity, and the chance to make a significant impact on patient care.